Plus: trade offs in clinical decision making; medication confusion; dapagliflozin for type 1
April 28, 2020 : DCMS #499 DISASTERS AVERTED — Near Miss Case Studies
Medication Confusion |
|
Letter from the Editor
When you read this week’s Disaster Averted, you will know why it is so hard for insulin using patients in the hospital in the best of times. When you add in the current crisis, and all the extra procedures and stresses, there is no wonder why medical errors, especially with insulin, are going through the roof.
The best advice is to have a protocol and make it a habit so nothing slides through the cracks.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
|
Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.
Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.
Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.
Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.
Visit Doctor's Option |
|
|
|
|
DISASTERS AVERTED — Near Miss Case Studies |
|
| Medication Confusion
A middle-aged woman, with mild obesity and type 2 diabetes, was hospitalized in the ICU, and the order on her chart was documented “Lispro 90 units at HS,” then the “9” was crossed off and a “6” written above it…. |
| |
|
|
TOP STORIES - Diabetes News and Research |
|
| How To Overcome The Complexities of Treatment Decisions For Your Patients with Type 2 Diabetes, Part 3 (Updated)
Part 3: Trade Offs — Clinical Decision Making for Patients with Type 2 Diabetes: In the previous series of articles, we discussed the complexity of clinical decision making and the role the cost plays into that decision. Cost is only one dimension of the complex process of deciding the appropriate next steps in the treatment of type 2 diabetes. In this article, we will discuss the other aspects of clinical decision making, and how clinicians can think about the trade-offs involved in making medication choices. |
| |
|
|
|
|
| | | | About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control. |
| Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com |
|
|
|
|
| | |
|
|
|
|
